FSGS

San Diego, California | April 13, 2026 Travere Therapeutics, Inc. has announced that the U.S. Food and Drug Administration...

Ingelheim, Germany | January 29, 2026 — Boehringer Ingelheim announced positive results from a 12-week Phase II clinical trial...

Miami, Florida – October 30, 2025 — Allosite Therapeutics, a biotechnology company pioneering allosteric integrin agonists for the treatment...